Stock ORGO ORGANOGENESIS HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Organogenesis Holdings Inc.

Equities

ORGO

US68621F1021

Real-time Estimate Cboe BZX
Other stock markets
 09:58:31 14/05/2024 pm IST 		5-day change 1st Jan Change
2.96 USD 0.00% Intraday chart for Organogenesis Holdings Inc. +21.52% -27.51%
13/05 Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating MT
10/05 Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup DJ

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup
DJ
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q1 Revenue $110M, vs. Street Est of $101.1M
MT
Organogenesis Holdings Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2024
CI
Organogenesis Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis
CI
Organogenesis Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q4 Revenue $99.7M, vs. Street Est of $109.1M
MT
Organogenesis Holdings Inc. Provides Earnings Guidance for the First Quarter and for the Year Ending December 31, 2024
CI
Organogenesis Holdings Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q3 Revenue $108.5M, vs. Street Est of $111.4M
MT
Organogenesis Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Organogenesis Holdings Inc. Provides Earnings Guidance for the Year Ending December 31, 2023
CI
Advanced Medical issues profit warning following royalty issues
AN
Advanced Medical Solutions Group Updates FY23 Guidance
MT
Organogenesis Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q2 Revenue $117.3M, vs. Street Est of $115.1M
MT
Organogenesis Holdings Inc. Withdraws Earnings Guidance for the the 2023
CI
Organogenesis Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Reports Q1 Revenue $107.6M
MT
Organogenesis Holdings Inc. Provides Earnings Guidance for the Fiscal Year 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ORGO Stock
  4. News Organogenesis Holdings Inc.
  5. Highlights
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW